ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Arch Therapeutics, Inc. (ARTH) stock remained unchanged at $0.24 a share on PNK. The stock opened at $0.24, fluctuating between $0.24 to $0.25 during the session.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
Employees | 8 |
Beta | 3.52 |
Sales or Revenue | $75.72K |
5Y Sales Change% | 0% |
Fiscal Year Ends | September |
Sector | Healthcare |
Industry | Biotechnology |